Cencora, Inc. (COR) stock
CORNYSEWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 14/3026% above fair value
$359.03+9.65 (+2.76%)
Close on Nov 13, 2026Market cap $68.51BP/E 26.7Yield 0.61%
Cencora operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Cencora's operating cash flow for the twelve months ending Jun 30, 2026 was $4.82B, up 176.7% year over year. For fiscal 2025 it was $3.88B, up 11.2% from the year before. Over ten years it grew -0.1% a year on average. The highest annual figure on record is $3.92B in fiscal 2015.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Sep 30, 2025 | $3.88B | +11.2% |
| FY2024 | Sep 30, 2024 | $3.48B | -10.9% |
| FY2023 | Sep 30, 2023 | $3.91B | +44.7% |
| FY2022 | Sep 30, 2022 | $2.70B | +1.4% |
| FY2021 | Sep 30, 2021 | $2.67B | +20.8% |
| FY2020 | Sep 30, 2020 | $2.21B | -5.8% |
| FY2019 | Sep 30, 2019 | $2.34B | +66.1% |
| FY2018 | Sep 30, 2018 | $1.41B | -6.2% |
| FY2017 | Sep 30, 2017 | $1.50B | -52.7% |
| FY2016 | Sep 30, 2016 | $3.18B | -19.0% |
| FY2015 | Sep 30, 2015 | $3.92B | +167.8% |
| FY2014 | Sep 30, 2014 | $1.46B | +85.8% |
| FY2013 | Sep 30, 2013 | $788.13M | -39.6% |
| FY2012 | Sep 30, 2012 | $1.31B | +11.8% |
| FY2011 | Sep 30, 2011 | $1.17B | +5.4% |
| FY2010 | Sep 30, 2010 | $1.11B | +41.4% |
| FY2009 | Sep 30, 2009 | $783.76M | +6.3% |
| FY2008 | Sep 30, 2008 | $737.07M | -39.0% |
| FY2007 | Sep 30, 2007 | $1.21B | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ2 2026 | Jun 30, 2026 | $2.65B | +2329.4% |
| Q2 FY2026CQ1 2026 | Mar 31, 2026 | $1.34B | -60.1% |
| Q1 FY2026CQ4 2025 | Dec 31, 2025 | -$2.31B | – |
| Q4 FY2025CQ3 2025 | Sep 30, 2025 | $3.13B | +213.2% |
| Q3 FY2025CQ2 2025 | Jun 30, 2025 | $109.25M | -95.6% |
| Q2 FY2025CQ1 2025 | Mar 31, 2025 | $3.35B | – |
| Q1 FY2025CQ4 2024 | Dec 31, 2024 | -$2.72B | -407.2% |
| Q4 FY2024CQ3 2024 | Sep 30, 2024 | $1.00B | -45.2% |
| Q3 FY2024CQ2 2024 | Jun 30, 2024 | $2.48B | +232.6% |
| Q2 FY2024CQ1 2024 | Mar 31, 2024 | -$878.44M | -239.5% |
| Q1 FY2024CQ4 2023 | Dec 31, 2023 | $885.16M | +24.7% |
| Q4 FY2023CQ3 2023 | Sep 30, 2023 | $1.83B | +56.9% |
| Q3 FY2023CQ2 2023 | Jun 30, 2023 | $744.94M | +82.3% |
| Q2 FY2023CQ1 2023 | Mar 31, 2023 | $629.51M | +136.1% |
| Q1 FY2023CQ4 2022 | Dec 31, 2022 | $710.08M | -17.8% |
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $1.16B | +15.3% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $408.62M | -66.2% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $266.59M | – |
| Q1 FY2022CQ4 2021 | Dec 31, 2021 | $863.41M | -4.4% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $1.01B | -22.3% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $1.21B | – |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | -$453.90M | -153.2% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $903.05M | +532.3% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $1.30B | +93.1% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | -$87.90M | -115.5% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $852.90M | +36.6% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $142.81M | -70.2% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $672.82M | +1.1% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $567.87M | -31.0% |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $624.36M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $478.97M | +4538.5% |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $665.35M | -51.8% |
| Q3 FY2018CQ2 2018 | Jun 30, 2018 | $823.29M | – |
| Q2 FY2018CQ1 2018 | Mar 31, 2018 | -$87.57M | -111.0% |
| Q1 FY2018CQ4 2017 | Dec 31, 2017 | $10.33M | – |
| Q4 FY2017CQ3 2017 | Sep 30, 2017 | $1.38B | +1.9% |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | -$244.70M | – |
| Q2 FY2017CQ1 2017 | Mar 31, 2017 | $798.74M | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | -$430.36M | – |
| Q4 FY2016CQ3 2016 | Sep 30, 2016 | $1.35B | – |
See a number that looks wrong?